Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

Clinical trial NCT07395050 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07395050
Sponsor: City of Hope Medical Center
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Stage 3 Type 1 Diabetes

Start date: 2026-09-01
Primary completion: 2026-09-14
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.